Myositis antibody screen
Myositis specific antibodies can be found in dermatomyositis (DM) and polymyositis (PM), idiopathic myositis, anti-synthetase syndrome and CTD overlap syndromes. These are a heterogeneous group of conditions characterised by proximal muscle weakness and non- infective inflammation of skeletal muscle. The anti-synthetase syndrome (ASS) consists of myositis, interstitial lung disease (ILD), mechanics hands, pyrexia, Raynauds and arthritis. Immune mediated necrotising myopathy (IMNM) is a subtype of myositis that presents with very high creatinine kinase (CK) and profound muscle weakness. Muscle biopsies show necrosis with limited infiltration of inflammatory cells.
The laboratory tests for a panel of myositis specific and associated antibodies by recombinant immunoblot. The current panel contains Mi-2α, Mi2b, TIF1γ, MDA5, NXP2, SAE1, Ku, PM-Scl100, PM-scl75, SRP and the anti-synthetase antibodies; Jo1 (histidyl-tRNA synthetase), PL7 (threonyl-tRNA synthetase), PL12 (alanyl-tRNA synthetase), EJ (glycyl tRNA synthetase), OJ (isoelucyl tRNA syntheatse), and the non-specific Ro52 antibody.
In ASS antibodies to Jo1, PL7 or EJ are associated with more muscle disease, and antibodies to PL7, OJ or PL12 to more severe ILD. Antibodies to SRP and HMGCoA reductase are strongly associated with IMNM. HMGCoA reductase antibodies are also associated with statin induced myositis. Antibodies to Mi2 and SAE are commonly associated with dermatomyositis with mild muscel disease.
Antibodies to TIF1γ, NXP2 and MDA5 are seen in around 50% of juvenile dermatomyositis patients and identify distinct disease subsets. In adults TIF1γ and NXP2 is found with myositis-associated cancer. MDA5 antibody in myositis or dermatomyositis is a risk factor for rapidly progressing (ILD) that can result in respiratory failure.
Pm/Scl antibodies are seen in scleroderma myositis overlap disease and Ku antibodies in CTD (SLE, Sjogren’s, Scleroderma)-myositis overlap syndromes.
McHugh, N., Tansley, S. Autoantibodies in myositis. Nat Rev Rheumatol 14, 290–302 (2018).
Suspected myositis
Muscle weakness and raised creatinine kinase
CT signs of ILD
CTD overlap syndromes
Negative
This test is currently awaiting UKAS accreditation due to an upgrade in kit format.
This test is not currently accredited
Record last updated
January 2, 2026
Sample Container
5ml RST Vacutainers (Rust top)
Search test database
Test Results
Yes, we have a Pathology User Guide
Yes. Please email your request to Imperial.nwlpcustomerservice@nhs.net
Results are communicated to clinical staff and are normally not communicated direct to patients either on telephone requests or in written report. If you need to contact us please click here to view the contact details page
Please contact the Customer Service Team Monday to Friday from 8:30am – 6:00pm on 0203 313 5353. Alternatively, see the Pathology User Guide for how to contact the relevant department. If advice is not urgent you can also email your query to Imperial.nwlpcustomerservice@nhs.net
Additional tests may be added by discussion with the relevant laboratory. The time limit for adding additional tests to a sample already received in the laboratory will depend on the type of sample and the department it was sent to.
Information on the repertoire of tests performed by pathology, including reference ranges, turnaround times and specimen requirements, can be found in the test directory.
Phlebotomy services are not managed by NWLP. For further information please see:
Imperial College Healthcare Trust Phlebotomy services
Chelsea and Westminster Hospital NHS Foundation Trust Phlebotomy services
NWLP operates UKAS accredited medical laboratories as per the references below. The current scope of accreditation for all NWLP’s laboratories can be found on the UKAS website.
UKAS accredited medical laboratory/medical diagnostic service:
- Clinical Biochemistry No. 8673
- Haematology and Blood Transfusion No. 8674
- Infection & Immunity Sciences (Including Immunology, Virology, Microbiology and Histocompatibility and Immunogenetics ) No. 8659
- Cellular Pathology (Including Histopathology, Cytology and Molecular Pathology) No. 9615
If you require copies of our certificate of accreditation and associated documentation please contact Imperial.nwlpcustomerservice@nhs.net.
UKAS requires the laboratories to be accredited for a particular repertoire/scope (ISO15189), any changes or additions to repertoire require assessment by UKAS (extension to scope).
The BD Hospital Tube Guide, BD GP Tube Guide and BD Paediatric Tube Guide provide visual references to the correct tube types and collection instructions.
Home testing
INSTRUCTION SHEET FOR BLOOD SAMPLE COLLECTION
We also have two instruction videos available (one with subtitles and one without) – please click on the links to view the videos on Google.
Our accreditations
Upholding excellence in diagnostic standards
Our laboratories are accredited by the UK Accreditation Service (UKAS) against the international standard ISO15189:2022. UKAS is the accreditation body for the UK that assesses medical laboratories.
Find out more about our accreditations on the UKAS website.
UKAS website